A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.
Sinagra
D
D
Greco
D
D
Amato
M C
MC
D'Acquisto
G
G
Galluzzo
A
A
D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage*; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds